| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/13/1997 | EP0788347A1 Stable reverse and multiple fluorocarbon emulsions |
| 08/13/1997 | EP0788346A1 Emulsified drug delivery systems |
| 08/13/1997 | EP0788345A1 Proteinaceous materials and formulations for sunburn cell protection |
| 08/13/1997 | EP0788308A1 Polymeric wound healing accelerators |
| 08/13/1997 | EP0689430B1 Superparamagnetic particles, process for producing the same and their use |
| 08/13/1997 | EP0531497B1 Oral delivery systems for microparticles |
| 08/13/1997 | CN1157002A Moisture barrier film coating composition, method, and coated products |
| 08/13/1997 | CN1156967A Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 08/13/1997 | CN1156964A Novel Peptides |
| 08/13/1997 | CN1156963A Long-acting oxytetracycline composition |
| 08/13/1997 | CN1156962A Cosolvent parenteral formulation of tirilazad |
| 08/13/1997 | CN1156961A Formulations and method for providing prolonged local anesthesia |
| 08/13/1997 | CN1156586A Transparent nanoemulsion based on silicone surfactants and use in cosmetics or in dermopharmaceuticals |
| 08/13/1997 | CA2197265A1 Target cell-specific vectors for inserting genes into cells, pharmaceuticals comprising such vectors and their use |
| 08/12/1997 | US5656666 Visibly reducing skin wrinkles |
| 08/12/1997 | US5656665 Method of using quinic acid or quinolactone for treating wrinkles |
| 08/12/1997 | US5656613 Treatment of hyperandrogenic conditions |
| 08/12/1997 | US5656611 Modified polynucleotide and copolymer having polyether segments and polycation segments; stabilizing polynucleic acids and increasing ability to cross cell membranes |
| 08/12/1997 | US5656598 Use of fibroblast growth factors to stimulate bone growth |
| 08/12/1997 | US5656308 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 08/12/1997 | US5656297 Modulated release from biocompatible polymers |
| 08/12/1997 | US5656293 Delivery system for enhanced onset and increased potency |
| 08/12/1997 | US5656292 Composition for pH dependent controlled release of active ingredients and methods for producing it |
| 08/12/1997 | US5656290 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| 08/12/1997 | US5656288 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 08/12/1997 | US5656286 Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| 08/12/1997 | US5656277 Nor- and homo- bile acids derivatives as absorption enhancers for medicaments |
| 08/12/1997 | US5656211 Apparatus and method for making gas-filled vesicles of optimal size |
| 08/07/1997 | WO1997028273A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
| 08/07/1997 | WO1997028165A1 Derivatives of camptothecin for use in treating cancer |
| 08/07/1997 | WO1997028104A2 Buffer systems for use in stabilizing pharmaceutical preparations |
| 08/07/1997 | WO1997027875A1 5α-REDUCTASE INHIBITORY PREPARATION FOR ORAL ADMINISTRATION, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF |
| 08/07/1997 | WO1997027871A1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/07/1997 | WO1997027870A1 Preventives and remedies for thrombocytopenia |
| 08/07/1997 | WO1997027868A1 Ovulation triggering drugs |
| 08/07/1997 | WO1997027844A1 Composition for transdermal delivery of drugs |
| 08/07/1997 | WO1997027842A1 Water soluble pharmaceutical coating and method for producing coated pharmaceuticals |
| 08/07/1997 | WO1997027841A1 Use of compositions comprising stabilized biologically effective compounds |
| 08/07/1997 | WO1997027837A1 New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use |
| 08/07/1997 | WO1997027750A1 Aqueous caffeine dosage forms |
| 08/07/1997 | DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents |
| 08/07/1997 | DE19703449A1 Stable, tissue compatible, injectable calcitonin solutions |
| 08/07/1997 | DE19648650A1 Buffer solution for stabilising pharmaceutical compositions |
| 08/07/1997 | CA2245715A1 5.alpha.-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof |
| 08/07/1997 | CA2244213A1 Buffer systems for stabilizing pharmaceutical preparations |
| 08/07/1997 | CA2242753A1 Composition for transdermal delivery of drugs |
| 08/07/1997 | CA2218398A1 Ovulation triggering drugs |
| 08/06/1997 | EP0787498A2 Therapeutic human albumin having a low aluminium binding capacity |
| 08/06/1997 | EP0787497A2 Pharmaceutical preparation containing human growth hormone |
| 08/06/1997 | EP0787487A1 Pharmaceutical granulates containing an intragranular disintegrant |
| 08/06/1997 | EP0787201A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 08/06/1997 | EP0787187A1 Her4 human receptor tyrosine kinase |
| 08/06/1997 | EP0787014A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 08/06/1997 | EP0787011A1 Pharmaceutical compositions |
| 08/06/1997 | EP0786986A1 Pharmaceutical compositions |
| 08/06/1997 | EP0786985A1 Method and composition for treatment of abnormal conditions of the epithelium of bodily orifices |
| 08/06/1997 | EP0786935A1 Method for destroying residual lens epithelial cells |
| 08/06/1997 | EP0667774B1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system |
| 08/06/1997 | EP0661989B1 Sustained-release protein formulations |
| 08/06/1997 | EP0611326B1 Method for producing nanocapsules with cross-linked protein-based walls, nanocapsules thereby obtained, and cosmetic, pharmaceutical and food compositions using same |
| 08/06/1997 | EP0610289B1 Formation of stable liposomes from lipid extracts of archaeobacteria (archaea) |
| 08/06/1997 | EP0585368B1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 08/06/1997 | EP0486499B1 Stable ascorbic acid compositions |
| 08/06/1997 | CN1156407A Topical ketoconazole emulsions |
| 08/06/1997 | CN1156404A Antibacterial oil-in-water emulsions |
| 08/06/1997 | CN1156403A Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
| 08/05/1997 | US5654422 Solubilizing drugs |
| 08/05/1997 | US5654403 Immunoglobulins stabilized with a chelator of copper ions |
| 08/05/1997 | US5654341 Mixture of cationic surfactant, fatty acid and oil |
| 08/05/1997 | US5654340 Method of using gulonic acid or gulonolactone for treating wrinkles |
| 08/05/1997 | US5654337 Topical formulation for local delivery of a pharmaceutically active agent |
| 08/05/1997 | US5654336 Methods of using glycolic acid for reversing or retarding the effect of aging on human facial skin |
| 08/05/1997 | US5654288 Stable NADH and NADPH compositions for sublingual administration |
| 08/05/1997 | US5654267 Wound healing agent |
| 08/05/1997 | US5654010 Composition for sustained release of human growth hormone |
| 08/05/1997 | US5654008 Preparation of biodegradable microparticles containing a biologically active agent |
| 08/05/1997 | US5654002 Piroxicam tablets and production and process thereof |
| 08/05/1997 | US5653999 Complexed with daunorubicin |
| 08/05/1997 | US5653998 With short-chain fatty acid stabilizers for active compounds from the dihydropyridines group |
| 08/05/1997 | US5653992 Polylactones; drug delivery |
| 08/05/1997 | US5653989 Lotion comprising hydrocortisone-21-acetate-17-propionate and selected water in oil emulsion; for use on dry skin |
| 08/05/1997 | US5653987 Liquid formulations for proteinic pharmaceuticals |
| 08/05/1997 | US5653986 Vaccine aganinst cholera |
| 08/05/1997 | US5653979 Immunotargeting of plasminogen activators to the pulmonary endothelium |
| 08/05/1997 | US5653972 Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
| 08/05/1997 | US5653959 Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients |
| 08/05/1997 | CA2105089C Encapsulated materials |
| 08/05/1997 | CA1339205C Oligonucleotide-polyamide conjugates |
| 08/05/1997 | CA1339199C Magnetic protein conjugates, a process for the preparation thereof, and the use thereof |
| 08/05/1997 | CA1339197C A tissue adhesive |
| 08/05/1997 | CA1339194C Mixture of alginates and polyacrylates and its use |
| 07/31/1997 | WO1997027219A1 Methods for purification and use of erythropoietin binding protein |
| 07/31/1997 | WO1997027049A1 Hyperpolarizable compounds and devices fabricated therefrom |
| 07/31/1997 | WO1997026919A2 Method of imaging amyloid deposits |
| 07/31/1997 | WO1997026918A2 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | WO1997026917A1 Composition for treating skin affections and process for its preparation |
| 07/31/1997 | WO1997026909A1 Highly concentrated, lyophilized, and liquid factor ix formulations |
| 07/31/1997 | WO1997026895A1 Avermectin formulation |
| 07/31/1997 | WO1997026879A1 Hydroxylamine compositions for the prevention or retardation of cataracts |
| 07/31/1997 | WO1997026869A1 Novel 'burst-free' sustained release poly-(lactide/glycolide) microspheres |